ASCO 2022 Conference Coverage
ASCO 2022 Analysis of the Effect of Systemic Corticosteroids on Survival From Tebentafusp in a Phase III Trial of Metastatic Uveal Melanoma
By
ASCO 2022 Conference Coverage
FEATURING
Alexandra Ikeguchi
By
ASCO 2022 Conference Coverage
FEATURING
Alexandra Ikeguchi
Login to view comments.
Click here to Login
